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doi:10.1016/j.jfma.2011.09.020Background/Purpose: This study aimed to develop and validate the Chinese Overactive
Bladder Symptom Score (OABSS) for assessing overactive bladder (OAB) symptoms and compare
it with a 3-day bladder diary.
Methods: The Chinese OABSS was developed by linguistic validation of the original version. Its
reliability and validity and correlations with a 3-day bladder diary were tested on patients with
OAB in a multicenter study conducted in Taiwan (the RESORT study).
Results: A total of 60 patients with OAB, either incontinent (OAB wet, nZ 31) or continent
(OAB dry, nZ 29), were enrolled consecutively in this study. The testeretest reliability of
the Chinese OABSS was moderate to good, with weighted kappa coefficients of 0.515e0.721
for each symptom score and 0.610 for the total symptom score. Each symptom score correlated
positively with the total OABSS (Spearman’s rho 0.365e0.793) and was internally consistent
(Cronbach’s alpha 0.674). The distribution of the OABSS showed a clear separation betweenof Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, 707, Section 3, Chung Yang
w (H.-C. Kuo).
ight ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.
Validation of Chinese Overactive Bladder Symptom Score 277OAB wet (average 11.4, range 7e15) and OAB dry (average 7.97, range 4e10) subgroups
(Wilcoxon exact test, p< 0.05). In addition, the OABSS items correlated positively with the
corresponding bladder diary variables (Spearman’s rho 0.504e0.879) and the degrees of agree-
ment improved with study visits except for nighttime frequency. The Chinese OABSS tended to
underestimate the frequency of nighttime voiding.
Conclusion: The Chinese OABSS has been developed and validated as a reliable instrument for
assessing OAB symptoms. OABSS can be an alternative to, but not a replacement for, a 3-day
bladder diary for assessing patients.
Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.17
Introduction
Overactive bladder (OAB) syndrome is defined by the
International Continence Society as urgency with or without
urgency incontinence, usually with frequency and nocturia
in the absence of proven infection or other obvious
pathology.1 A subsequent statistical analysis confirmed that
urgency is the cornerstone symptom of OAB, and there are
at least two distinctive subtypes of OAB, i.e., OAB wet
(with urgency incontinence) and OAB dry (without urgency
incontinence).2 OAB, especially OAB wet, has a negative
impact on individuals’ quality of life, interfering with daily
activities, travel, and sleep/vitality.2,3 Epidemiological
studies have demonstrated that the frequency of OAB
ranges from 12.4% to 53.1%, depending on the target pop-
ulation and definition of OAB, and the number increases
with advancing age.4e11 OAB syndrome is treated with
behavior therapy, electrostimulation, and, most commonly,
antimuscarinic agents.12
Because OAB is defined by subjective symptoms, rather
than objective measures, the patient’s perspective is
important in managing OAB. To capture the patient’s
perspective, i.e., symptoms and their impact on quality of
life, several patient-reported outcome instruments are
available, including the Overactive Bladder Questionnaire
(OAB-q), Patient Perception of Bladder Condition (PPBC),
Urgency Questionnaire, and the Primary OAB Symptom
Questionnaire.13 However, most of these available measures
do not actually evaluate the symptoms of OAB, but rather
assess the effects they have on daily life. Although the
Overactive Bladder Symptom Composite Score14 is an
exception which can quantify symptoms in a single score, it
does, however, require keeping a record in a bladder diary,
which limits its range of use.
A bladder diary can provide accurate information about
OAB symptoms.15 However, keeping such a diary can be
a burden for patients because they have to keep a diary for
several consecutive days, and usually have to carry
a reservoir with them at all times in order to measure
voided volumes.16 Previous studies 15,16 have shown that
a voiding diary completed for 3-4 days, following detailed
instructions, was as reliable and valid for documenting the
symptoms of OAB as that kept for 7 days. Therefore, a 3-
day bladder diary is usually used.
Recently, Homma et al. have developed and validated
a new assessment tool for OAB symptoms, the Overactive
Bladder Symptom Score (OABSS). The OABSS total score
is the sum of four symptom scores, based on a self-
administered questionnaire relating to four areas:
daytime frequency, nighttime frequency, urgency, andurgency incontinence. OABSS evaluates symptoms from
the patients’ viewpoint and has been demonstrated to have
high correlations with corresponding bladder diary vari-
ables.18 OABSS has some advantages over other scales for
OAB symptoms, but the disadvantages are that it was
written in Japanese and validated using data from Japanese
patients only. In order to use OABSS outside Japan, it needs
to be translated into the local language and validated based
on local patient data.
The present study (RESORT: Reproducibility Study of
OABSS and its Response to Treatment) consists two parts to
conduct the validation of a traditional Chinese version of
the OABSS with Taiwanese patients. Part One is the repro-
ducibility study, which evaluates the reliability and validity
of the Chinese OABSS and its correlations with other
measures of OAB, including a 3-day bladder diary and PPBC.
Part Two, the responsiveness study, compares the Chinese
OABSS scores before and after pharmacotherapy with an
antimuscarinic agent, solifenacin (5 mg/d). In this manu-
script, we report the results for the Part One (reproduc-
ibility) study.
Materials and methods
Development of Chinese OABSS
A standard linguistic validation process was conducted to
ensure conceptual equivalence between the Chinese
translations and the original OABSS using the methods
described by Acquadro et al.19
Validation of Chinese OABSS
A total of 60 consecutive patients with OAB who visited
seven different hospitals in Taiwan were enrolled in this
study. A brief protocol including the study calendar and
inclusion/exclusion criteria for enrolling patients is shown
in Supplement 1.
Patients completed the Chinese OABSS at enrollment
and repeated the questionnaire after a nontreatment
period of 2 weeks (Part Onedthe reproducibility study).
Patients who took part in Part Twodthe responsiveness
studydanswered the questionnaire again at 4 and 12 weeks
after pharmacological treatment with the animuscarinic
agent solifenacin (5 mg/d). Patients also completed a 3-day
bladder diary and PPBC at each study visit (a total of four
visits). An analysis was conducted to evaluate the reliability
and validity of the Chinese OABSS and the correlations with
a 3-day bladder diary and PPBC, respectively.
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the study protocol was approved by the Joint Institutional
Review Board (JIRB) in Taiwan as well as by the institutional
review boards at each hospital.
Statistical analysis
Testeretest reliability of the Chinese OABSS was evaluated
by comparison of the variations between the baseline and
the 2 weeks’ assessment with weighted kappa analysis. The
internal consistency of the questionnaire was analyzed
using Spearman’s rho and Cronbach’s alpha. The difference
in score distribution between the OAB subgroups was
examined using the Wilcoxon exact test. Correlations and
agreements between an OABSS item and the corresponding
diary variable were examined using the Spearman’s coef-
ficient and weighted kappa coefficient, respectively. For
this analysis, the corresponding diary variable was con-
verted into the same discrete categories as the OABSS item.
The correlations between the OABSS and the PPBC were
tested by Spearman’s rho.
For interpreting correlation coefficients, the guidelines
proposed by Cohen were used, with a coefficient of 0.1
being low, 0.3 being moderate, and 0.5 being high.20 Kappa
coefficients were interpreted using the guidelines provided
by Altman as follows: kappa values less than 0.2 represent
poor agreement; values of 0.21e0.40, fair agreement;
values of 0.41e0.60, moderate agreement; values of
0.61e0.8, good agreement; and values of 0.81e1.00, very
good agreement.21 All statistical tests were two-tailed and
conducted with a significance level of 0.05. SAS software
(SAS Institute, Cary, NC, USA) was used for statistical
computations.
Results
Development of Chinese OABSS
The finalized Chinese OABSS is shown in Supplement 2. A
pretest was conducted on 15 patients with OAB, who
confirmed that the questionnaire was clearly worded, was
relevant to patients’ complaints, and did not neglect any
important symptoms. The questionnaire is a symptom
assessment instrument designed to quantify the symptoms
of OAB into a single score, and contains questions about the
four symptoms of OABddaytime frequency, nighttime
frequency, urgency, and urgency incontinence. Patients
were asked to rate their symptom severity during the
previous 2 weeks on scales with maximum scores of 2, 3, 5,
and 5, respectively. The total score ranged from 0 to 15,
and more severe OAB symptoms were indicated by a higher
score.
Validation of Chinese OABSS
A total of 60 patients with OAB, either incontinent (OAB
wet; nZ 31) or continent (OAB dry; nZ 29), were
consecutively enrolled in the study. Each patient answered
the questionnaire at time of enrollment and repeated it
after a 2-week nontreatment period. Patient characteristicsand the baseline OABSS are shown in Table 1. The average
age, body mass index (BMI) values, total OABSS score and
“urgency incontinence” symptom score were significantly
higher in the OAB wet subgroup than in the OAB dry
subgroup as determined by univariate analysis (p< 0.05).
The other symptom scores were not significantly different
between groups.
The Chinese OABSS had moderate to good testeretest
reliability with the weighted kappa coefficients ranging
between 0.515 and 0.721 for each symptom score and being
0.610 (95% confidence interval 0.488e0.731) for the total
symptom score. In addition, tests on the reliability of
internal consistency showed that each symptom score
correlated positively with the total OABSS score (Spear-
man’s rho 0.365e0.793) and were internally consistent
(Cronbach’s alpha 0.674). The discriminate validity of the
questionnaire was good as it showed a clear separation
between the OAB wet (average 11.4, range 7e15) and OAB
dry (average 7.97, range 4e10) subgroups (Wilcoxon exact
test, p< 0.05) (Fig. 1).
Analysis of the correlations between the questionnaire
and a 3-day bladder diary showed that the OABSS items
correlated positively with the corresponding bladder diary
variables (Spearman’s rho 0.504e0.879), and the degree of
agreement evaluated by weighted Kappa coefficients
improved with study visits (from visit 1 to visit 4) except for
nighttime frequency (Fig. 2). Further analysis indicated
that the OABSS tended to underestimate the frequency of
nighttime voiding as recorded in a bladder diary. In addi-
tion, the Chinese OABSS had only low to moderate corre-
lations with the PPBC (Spearman’s rho 0.169e0.313).
We performed a correlation analysis between age and
OABSS item and total score. Questions 1 (frequency), 2
(nocturia), and 3 (urgency) did not correlate with age (all
p> 0.05) but Question 4 (urgency incontinence) and total
OABSS score did (p< 0.0001). However, there was no
significant difference in the OABSS symptom and total score
between the male and female subgroups (Table 2).Discussion
Our study results indicated that the questionnaire is as
reliable and valid as the original instrument to assess OAB
symptoms.17 However, we also found some differences
between the present results and those from previous
studies on the original OABSS. One difference is that the
correlations between the Chinese OABSS and 3-day bladder
diaries were high throughout the study visits; however, the
degree of agreement between the two instruments
improved to a good level only after the initial concomitant
recordings. In contrast, both the correlations and degree of
agreement were good at baseline and 12 weeks after
treatment in the study conducted by Homma et al.18
Another difference is that the Chinese OABSS had only
low to moderate correlations with the PPBC. In contrast,
the correlations were moderate to good in the study con-
ducted by Homma et al.22
Homma et al made a comparison between the OABSS and
a 3-day bladder diary for assessing OAB symptoms before
and after medical treatment. High correlations (Spear-
man’s rho  0.5) and a fairly good agreement (kappa
Table 1 Patient data and symptom scores for the three patient groups.
Score OAB OAB wet OAB dry
Patients (M/F) d 60 (14/46) 31 (7/24) 29 (7/22)
Age (y) Mean SD 55.3 13.8 61.5 14.0 48.6 10.2
p OAB wet vs. OAB dry pZ 0.000
Body mass index (kg/m2) Mean SD 24.1 4.44 25.3 4.75 22.8 3.71
p d OAB wet vs. OAB dry pZ 0.026
Question 1 0 1 1 0
Daytime frequency 1 38 19 19
2 21 11 10
p d OAB wet vs. OAB dry pZ 0.868
Mean 1.33 1.32 1.35
Question 2 0 5 3 2
Nighttime frequency 1 9 6 3
2 9 3 6
3 37 19 18
p OAB wet vs. OAB dry pZ 0.562
Mean 2.30 2.23 2.38
Question 3 0 0 0 0
Urgency 1 0 0 0
2 2 1 1
3 8 3 5
4 18 9 9
5 32 18 14
p d OAB wet vs. OAB dry pZ 0.415
Mean 4.33 4.42 4.24
Question 4 0 29 0 29
Urgency incontinence 1 2 2 0
2 4 4 0
3 7 7 0
4 15 15 0
5 3 3 0
p d OAB wet vs. OAB dry pZ 0.000
Mean 1.77 3.42 0
OABSS Range 4e15 7e15 4e10
p d OAB wet vs. OAB dry pZ 0.000
Mean SD 9.73 2.60 11.4 2.28 7.97 1.57
OABZ overactive bladder; OABSSZOveractive Bladder Symptom Score; SDZ standard deviation.
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and the corresponding diary variables were found. The
authors suggested that the OABSS could be an alternative to
a bladder diary for assessing symptoms and efficacy in daily
clinical practice because of the simplicity and depend-
ability of the questionnaire.18
In this study, the Chinese version of the OABSS assessed
the voiding condition within previous 2 weeks rather than
previous 1 week, as designed by Homma. We chose this
longer screening period because we believed 1 week too be
too short a time to assess OAB. The symptoms of OAB might
occur due to acute conditions such as a small ureteral
stone, occult inflammatory pelvic floor disorders, con-
stipation, etc. Since OAB is a chronic bladder condition, the
assessment of constant symptoms for 2 weeks seems more
reasonable.
In the present study of the Chinese OABSS, we found
that the correlations between the two instruments werehigh throughout the four study visits, but the degree of
agreement improved to a good level after two concomitant
recordings at the testeretest study. The results suggested
that keeping a diary for 3 days when the Chinese OABSS was
administered may have had an educational effect on
patients’ insight into their bladder conditions, and then an
increase in agreement occurred between the two instru-
ments. However, even after several concomitant record-
ings, the Chinese OABSS still tended to underestimate the
frequency of nighttime voiding as recorded in the bladder
diaries. This phenomenon is hard to explain but it may be
due to the scale pattern used for “nighttime frequency” on
the Chinese OABSS or due to the difficulty in patient recall
of nighttime voiding.
The PPBC is a validated global measure for OAB and has
been shown to have significant correlations with other
measures such as bladder diaries and the OAB-q.23 Homma
et al also found OABSS correlated relatively closely with the
Figure 1 Distribution of Overactive Bladder Symptom Score
(OABSS). OABSS showed a clear separation between OAB wet
and OAB dry patients.
280 M.-J. Hung et al.PPBC and the OAB-q (Spearman’s rho 0.36e0.57).22 In
contrast, the correlations of the Chinese OABSS with the
PPBC were low to moderate (Spearman’s rho 0.169e0.313)
in the present study. We suggest that since the PPBC
contains only a single question to evaluate whether
patients are bothered by their bladder symptoms, it is
subject to daily variations depending on various environ-
mental or personal factors other than their bladder
symptoms.
Matza et al have conducted a study to evaluate the
testeretest reliability of four patient-reported outcome
measures for OAB. The testeretest reliability of the PPBC
was somewhat weaker than that for the other three multi-
item measures, i.e., the OAB-q, the Urgency Questionnaire,
and the Primary OAB Symptom Questionnaire.13 Therefore,
a multi-item disease-specific questionnaire to assess the
impact of OAB symptoms on a patient’s quality of life may
be a better instrument than the PPBC. In future, it would beFigure 2 Changes in degrees of agreement (weighted Kappa
coefficient) between Overactive Bladder Symptom Score
(OABSS) items and the corresponding diary variables at
different study visits.helpful to develop and validate a Chinese version of
a quality of life questionnaire with multiple items to pair
with the Chinese OABSS for assessing patients.
In the general population, approximately one-third of
OAB patients are incontinent (OAB wet).4e11 However, the
number of OAB wet (nZ 31) and OAB dry (nZ 29) patients
was similar in the present study, which may be due to the
higher number of female patients enrolled in this study
(nZ 46; 76.7%). Previous epidemiological studies have
shown that, in addition to advancing age and increasing BMI
values, female gender is a predisposing factor associated
with urgency incontinence in OAB patients.2,5 In this study,
we found similar results to those of previous studies:
compared with OAB dry patients, OAB wet patients had
significantly higher BMI values, average age, urgency
incontinence scores, and total scores on the OABSS (Table
1). However, we did not find a significant difference in
OABSS total or single item score between men and women,
suggesting that both genders are affected by OAB to similar
degrees.
OAB, especially OAB wet, has a negative impact on
individuals’ quality of life.3 OAB wet patients also make
more adaptive efforts in their daily life than OAB dry
patients.2 Therefore, OAB wet is usually considered to be
a severe subtype of OAB. The analysis of the distribution of
the total OABSS showed a clear separation between OAB
wet and OAB dry subgroups in the present study (Fig. 1) as
well as in the study conducted by Homma et al.17 There-
fore, both studies similarly discriminated patients with OAB
according to their symptom severity.
Recent epidemiological studies have shown that the
prevalence of OAB is similar across the Eastern and the
Western world when using the same definition given by the
International Continence Society.6,9e11 However, there is
a lower level of public awareness and healthcare-seeking
behavior in the East. An early survey on OAB conducted
in 11 Asian countries reported that only 21.1% of females
and 5.9% of males sought treatment for their OAB.7,8
Recent surveys conducted in Taiwan10 and in Japan9
showed that only 13.0% of Taiwanese and 23% of Japa-
nese individuals whose quality of life was affected by their
urinary problems had visited a medical institution for
consultation. In contrast, the EPIC study, the largest pop-
ulation survey in five Western countries to date, reported
a 60% rate of consultation with a doctor.6 OAB is an
underreported and undertreated condition in the East,
especially in Asian countries, which warrants closer
attention.
Since the Chinese population is so large, the validated
Chinese OABSS could be a very useful clinical tool or
research instrument. Due to its simplicity and depend-
ability, we suggest that the Chinese OABSS be used as a tool
to screen patients with OAB across the general population
to increase public awareness and healthcare-seeking rates
in this area. However, one concern is that the Chinese
OABSS was developed and validated in Taiwan using
Taiwanese patients and traditional Chinese characters.
There are, however, many differences between simplified
Chinese and traditional Chinese characters. Therefore, the
traditional Chinese OABSS cannot be applied directly to
other Mandarin-speaking areas; it may only be suitable for
the Taiwanese population. In future, it may be necessary to
Table 2 The difference in OABSS by gender at visit 1.
Q1 Q2 Q3 Q4 Total OABSS
Male (nZ 14) 1.36 0.50 2.21 1.05 4.43 0.76 1.79 2.00 9.79 2.81
Female (nZ 46) 1.33 0.52 2.33 1.01 4.30 0.87 1.76 1.86 9.72 2.57
p 0.844 0.721 0.631 0.966 0.932
OABSSZOveractive Bladder Symptom Score.
Validation of Chinese Overactive Bladder Symptom Score 281modify and revalidate the Chinese OABSS if it is to be used
in other Mandarin-speaking areas where different dialects
and cultural backgrounds exist.
A limitation of this study was the lack of a control group
or other disease groups. Moreover, the weighing of the
symptom scores of the OABSS is based on epidemiological
study conducted in Japan and might not be justified for
patients residing outside Japan. Further studies with larger
patient numbers, a control group, and other disease groups
in Taiwan should be conducted to further validate the
Chinese OABSS.
Conclusion
The Chinese OABSS has been developed and validated as
a reliable instrument to assess patients with OAB.
Acknowledgments
This study was supported by Astellas Pharmaceutical
Company, Taiwan. We sincerely thank Professor Yukio
Homma for generously providing help in linguistic validation
of the OABSS. Professor Pao-Sheng Shen from the Depart-
ment of Statistics, Tung-Hai University, Taichung, Taiwan,
provided great help in the statistical analysis.Supplementary material
Supplementary material associated with this article can be
found, in the online version, at doi:10.1016/j.jfma.2011.
09.020.References
1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U,
et al. The standardization of terminology of lower urinary tract
function: report from the Standardisation Sub-committee of
the International Continence Society. Neurourol Urodyn 2002;
21:167e78.
2. Hung MJ, Ho ES, Shen PS, Sun MJ, Lin AT, Chen GD. Urgency is
the core symptom of female overactive bladder syndrome, as
demonstrated by a statistical analysis. J Urol 2006;176:
636e40.
3. Abrams P, Kelleher CJ, Kerr LA, Rogers RG. Overactive bladder
significantly affects quality of life. Am J Manag Care 2000;
6(Suppl. 11):S580e90.
4. Milsom I, Abrams P, Cardozo L, Roberts RG, Thu¨roff J, Wein AJ.
How widespread are the symptoms of an overactive bladder
and how are they managed? A population-based prevalence
study. BJU Int 2001;87:760e6.5. Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR,
Corey R, et al. Prevalence and burden of overactive bladder in
the United States. World J Urol 2003;20:327e36.
6. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S,
et al. Population-based survey of urinary incontinence,
overactive bladder, and other lower urinary tract symptoms in
five countries: results of the EPIC study. Eur Urol 2006;50:
1306e15.
7. Lapitan MC, Chye PL. Asia-Pacific Continence Advisory Board.
The epidemiology of overactive bladder among females in Asia:
a questionnaire survey. Int Urogynecol J Pelvic Floor Dysfunct
2001;12:226e31.
8. Moorthy P, Lapitan MC, Quek PL, Lim PH. Prevalence of over-
active bladder in Asian men: an epidemiological survey. BJU Int
2004;93:528e31.
9. Homma Y, Yamaguchi O, Hayashi K; Neurogenic Bladder Society
Committee. An epidemiological survey of overactive bladder
symptoms in Japan. BJU Int 2005;96:1314e8.
10. Yu HJ, Liu CY, Lee KL, Lee WC, Chen TH. Overactive bladder
syndrome among community-dwelling adults in Taiwan: preva-
lence, correlates, perception, and treatment seeking. Urol Int
2006;77:327e33.
11. Lee YS, Lee KS, Jung JH, Han DH, Oh SJ, Seo JT. Prevalence of
overactive bladder, urinary incontinence, and lower urinary
tract symptoms: results of Korean EPIC study. World J Urol
2011;29:185e90.
12. Yoshimura N, Chancellor MB. Current and future pharmaco-
logical treatment for overactive bladder. J Urol 2002;168:
1897e913.
13. Matza LS, Thompson CL, Krasnow J, Brewster-Jordan J,
Zyczynski T, Coyne KS. Test-retest reliability of four ques-
tionnaires for patients with overactive bladder: the Overactive
Bladder Questionnaire (OAB-q), Patient Perception of Bladder
Condition (PPBC), Urgency Questionnaire (UQ), and the
Primary OAB Symptom Questionnaire (POSQ). Neurourol Uro-
dyn 2005;24:215e25.
14. Zinner N, Harnett M, Sabounjian L, Sandage Jr B, Dmochowski R,
Staskin D. The overactive bladder-symptom composite score:
a composite symptom score of toilet voids, urgency severity and
urge urinary incontinence in patients with overactive bladder. J
Urol 2005;173:1639e43.
15. Brown JS, McNaughton KS, Wyman JF, Burgio KL, Harkaway R,
Bergner D, et al. Measurement characteristics of a voiding
diary for use by men and women with overactive bladder.
Urology 2003;61:802e9.
16. Ku JH, Jeong IG, Lim DJ, Byun SS, Paick JS, Oh SJ. Voiding diary
for the evaluation of urinary incontinence and lower urinary
tract symptoms: prospective assessment of patient compliance
and burden. Neurourol Urodyn 2004;23:331e5.
17. Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M,
et al. Symptom assessment tool for overactive bladder syn-
dromedoveractive bladder symptom score. Urology 2006;68:
318e23.
18. Homma Y, Kakizaki H, Yamaguchi O, Yamanishi T, Nishizawa O,
Yokoyama O, et al. Assessment of overactive bladder symp-
toms: comparison of 3-day bladder diary and the Overactive
Bladder Symptoms Score. Urology 2011;77:60e4.
282 M.-J. Hung et al.19. Acquardo C, Kopp Z, Coyne KS, Corcos J, Tubaro A, Choo MS,
et al. Translating overactive bladder questionnaires in 14
languages. Urology 2006;67:536.
20. Cohen J. Statistical power analysis for the behavioral sciences.
2nd ed. Philadelphia: Lawrence Erlbaum Associates; 1988.
21. Altman DG. Practical statistics for medical research. 2nd ed.
London: Chapman & Hall; 1992.22. Homma Y, Gotoh M. Symptom severity and patient perceptions
in overactive bladder: how are they related? BJU Int 2009;
104:968e72.
23. Coyne KS, Matza LS, Kopp Z, Abrams P. The validation of the
patient perception of bladder condition (PPBC): a single-item
global measure for patients with overactive bladder. Eur Urol
2006;49:1079e86.
